COMMUNIQUÉS West-GlobeNewswire

-
New 3-Year Phase 3 Data Confirmed Sustained Response to TransCon® PTH (Palopegteriparatide) Therapy in Adults with Hypoparathyroidism, Including Improvements in Biochemistries, Kidney Function, and Quality of Life
14/07/2025 -
Branded Legacy Inc. Announces Leadership Transition and Pending Merger with Innovative Addiction Therapeutics Company Projecting $40 Million in First-Year Revenue
14/07/2025 -
Muscle Endurance: Bodybuilders Turn to CrazyBulk Natural Legal Steroids and BodyBuilding Supplements For Muscle Growth
14/07/2025 -
Strength Training For Women: CrazyBulk Legal Steroid Alternatives Are Changing the Muscle Building Supplements Game
14/07/2025 -
The Foundation for Sarcoidosis Research Awards $450,000 to Support Early-Career Investigators Through the 2025 Fellowship Grant
14/07/2025 -
Ascentage Pharma Announces Pricing of Top-Up Placement
14/07/2025 -
TTAM Research Institute, A Nonprofit Public Benefit Corporation, Completes The Acquisition of 23andMe Assets
14/07/2025 -
Tevogen.AI Builds Alpha Version of PredicTcell™ Model with Microsoft and Databricks; Observes Drastic Time Reduction in Target Analysis Translating to Potential Savings of Billions in Drug Development Costs
14/07/2025 -
Positive Response Fuels New Efforts by Dr. Anosh Ahmed and the Anosh Inc. Foundation to Support Families of Fallen Officers and FBI Agents
14/07/2025 -
Dr. Anosh Ahmed Foundation Launches Chicago-Based Initiative to Support Families of Fallen FBI Agents and Law Enforcement Officers
14/07/2025 -
BiomX Announces Successful Initiation of Phase 2b Trial with First Patient Dosed in BX004 Program in Patients with Cystic Fibrosis
14/07/2025 -
Pineapple, Inc. to Launch Real-World Asset Token Designed to Monetize Intellectual Property
14/07/2025 -
NEXGEL and STADA AG Announce Expansion of Partnership for North America
14/07/2025 -
Borvo EVAC™ System Demonstrates 100% Success Rate in Chronic Subdural Hematoma Clinical Cases Validated Across 5 Medical Centers
14/07/2025 -
Journey Medical Corporation Announces Expanded Payer Coverage for Emrosi™
14/07/2025 -
Vivos Inc. Submitted the Investigational Device Exemption (IDE) Application for Human Clinical Trials at Mayo Clinic
14/07/2025 -
Disc Medicine Appoints Nadim Ahmed to its Board of Directors
14/07/2025 -
Salarius Pharmaceuticals Granted Additional Extension to Regain Compliance with Nasdaq’s Stockholders’ Equity Standard
14/07/2025 -
Biodexa Announces Filing of CTA in Europe for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP)
14/07/2025
Pages